Aflatoxin M1 Levels Research Articles

Prevalence and concentration of aflatoxin M1 in milk and dairy products: an umbrella review of meta-analyses.

Aflatoxin M1 (AFM1) is a derivative of aflatoxin B1 and a significant contaminant of milk and dairy products. In this study, we implemented an umbrella review of all existing systematic reviews and meta-analyzing studies to apprise and summarize the worldwide prevalence and level of AFM1 in milk and dairy products. We conducted a systematic review of structured review and meta-analysis articles published in English until January 2024, with no time limit. Articles were sourced from reputable databases, including PubMed/MEDLINE, EMBASE, Scopus, Web of Science, CINAHL and the Cochrane Database of Systematic Reviews. Relevant studies from Google Scholar were also included. The overall prevalence of AFM1 in all dairy products was 66.2% (95% CI 60.6 to 71.9%), with high heterogeneity (I²=99.7%, Q statistic=2221.03, p<0.0001). The prevalence for specific dairy products was as follows: raw milk, 64.8% (95% CI 60.9 to 68.7%); pasteurized milk, 88.7% (95% CI 81.6 to 95.7%); sterilized milk, 71.0% (95% CI 67.2 to 74.8%); ultra-high temperature processing (UHT) milk, 67.9% (95% CI 64.9 to 70.9%); yogurt, 58.8% (95% CI 42.5 to 75.1%); doogh, 17.2% (95% CI 13.9 to 20.5%); and cheese 49.8% (95% CI 47.8 to 51.9%). The overall mean concentration of AFM1 across all dairy products was 57.22 ng/kg (95% CI 46.95 to 67.49), with significant heterogeneity (I²=99.7%, Q statistic=2221.03, p<0.0001). Mean AFM1 levels (ng/kg) for each dairy product were as follows: raw milk, 52.51 (95% CI 40.96 to 64.05); pasteurized milk, 71.14 (95% CI 48.81 to 93.47); sterilized milk, 60.10 (95% CI 30.90 to 89.30); UHT milk, 82.57 (95% CI 35.30 to 129.85); yogurt, 46.74 (95% CI 24.27 to 69.21); and doogh, 41.60 (95% CI 32.60 to 50.60). In total, these results highlight the importance of increasing the regulation of animal feed, reducing aflatoxin B1 (AFB1) in animal feed, and monitoring AFM1 in dairy products, particularly raw and heated milk.

Spatial Distribution and Dietary Risk Assessment of Aflatoxins in Raw Milk and Dairy Feedstuff Samples from Different Climate Zones in China.

This study aimed to explore the contamination of aflatoxins by investigating the spatial distribution of aflatoxin B1 (AFB1) in cow feedstuff and aflatoxin M1 (AFM1) in raw milk, and the potential health risks of AFM1 in milk and dairy products. Feedstuff and raw milk were collected from 160 pastures in three climate zones of China from October to November 2020. The results indicated the level of AFB1 and AFM1 ranged from 51.1 to 74.1 ng/kg and 3.0 to 7.0 ng/kg, respectively. Spatial analysis indicated the contamination was mostly concentrated in the temperate monsoon climate zone. On average, the estimated dietary exposure to AFM1 from milk and dairy products for Chinese consumers ranged from 0.0138 to 0.0281 ng/kg bw/day, with the MOE values below 10,000, and liver cancer risk of 0.00004-0.00009 cases/100,000 persons/year. For different groups, the average exposure to AFM1 was highest in the temperate monsoon climate zone and for toddlers.

Assessing aflatoxin exposure in the United Arab Emirates (UAE): Biomonitoring AFM1 levels in urine samples and their association with dietary habits.

Aflatoxins, known for their carcinoginc properties and produced by Aspergillus fungi, pose a substantial threat to public health, particularly in regions with hot and humid climates, where individuals are exposed to these toxins through contaminated food. The primary objective of this study was to assess the extent of aflatoxin exposure in the Emirate of Sharjah employing Aflatoxin M1 (AFM1) as a biomarker in urine samples from adult participants. Furthermore, this study aimed to explore the relationship between dietary habits and AFM1 levels in order to establish a potential link. In a cross-sectional study design, a total of 144 adults (73 females and 71 males) were recruited for participation. The urine samples obtained from participants were subjected to analysis for AFM1 concentrations utilizing the enzyme-linked immunosorbent assay (ELISA) method. Additionally, structured questionnaires were administered to collect information on the dietary and lifestyle habits of the participants. To explore the relationship between dietary factors and AFM1 levels, various statistical analyses, including linear regression and the Mann-Whitney U test, were performed. AFM1 was detected in 69 % of the samples under invstigation, wherein males exhibited a higher mean level (0.912 ng/mg creatinine) in comparison to females (0.676 ng/mg creatinine). The overall mean concentration of AFM1 was determined to be 0.792 ng/mg creatinine. It is worth noting that there was a significant correlation between rice consumption and heightened AFM1 exposure among males, while no such correlation was observed among females. This study conducted in the UAE provides novel perspectives on aflatoxin exposure, shedding light on the gender-specific correlation between rice consumption and aflatoxin levels among males. These findings hold significant implications for guiding public health interventions and underscore the pivotal role of ongoing surveillance and stringent food safety regulations in mitigating the hazards associated with aflatoxin contamination.

Determination of aflatoxin M1 levels in cheese in Iran’s market

Determination of aflatoxin M1 levels in cheese in Iran’s market

On-farm evaluation of aflatoxin binder inclusion in dairy feed as a strategy to reduce milk aflatoxin M1 contamination in the Rwandan context.

Aflatoxins (AF), fungal metabolites, can contaminate feed in favorable environments, posing health risks to humans and animals. Dairy cows exposed to aflatoxin B1 (AFB1) excrete its metabolite, aflatoxin M1 (AFM1), in milk, compromising its safety. The current study examined the use of an AF binder in dairy feed concentrates on farms in Rwanda to mitigate AFM1 in milk. It was conducted in Nyagatare district, peri-urban areas of Kigali (Center), and Huye district (South) with 42 farmers randomly selected from a previous study evenly divided into control and intervention groups. The intervention group received an AF binder (Novasil™ Plus) and training on both the usage of the binder and AF prevention in dairy feed. Sociodemographic and dairy management data were collected through semi-structured questionnaires. Farmers in both the treatment and control groups were visited at regular intervals over a 3-month time period (five total visits per farmer) to collect samples of milk and feed for the quantification of AFM1 and AFB1, respectively, and to interview participants. The use of the AF binder evidenced a significant reduction in milk AFM1 contamination between the intervention (mean, 0.15µg/l; median, 0.13µg/l) and control groups (mean, 0.30µg/l; median, 0.24µg/l) (p < 0.05). AFB1 was detected in the feed concentrate at a mean concentration of 32.2µg/kg (median, 36.2µg/kg); however, mean AFM1 levels in both groups (i.e., control and intervention) did not exceed the Rwanda Standards Board (RSB) regulatory limit of 0.5µg/kg AFM1. AF binders show potential as a low-cost strategy to reduce AFM1 contamination in the Rwandan context. However, there is a need for clear standards on the registration and use of binders before they are deployed in-country and to claim their mitigating effects on AFM1 in milk.

Assessment of the ability of Lactococcus lactis 537 to bind aflatoxin M1 in the presence of inulin and Terminalia ferdinandiana (Kakadu plum)

One promising method for the detoxification of Aflatoxin M1 (AFM1) involves the use of probiotic bacteria combined with prebiotics. This approach is both safe and cost-effective, while also offering additional health benefits. The objective of this study was to investigate the capacity of Lactococcus lactis 537 (Lc. Lactis 537) to bind AFM1 in milk and phosphate-buffered saline (PBS), either in the presence or absence of inulin or Kakadu plum fruit powder (KP), which are prebiotic substances. Lc. Lactis 537 was incubated for 0, 1, 2, and 24 h at 30 °C, with or without inulin or KP, to assess its ability to bind and reduce AFM1 levels. The concentration of AFM1 was determined using liquid chromatography-mass spectrometry (LC-MS9) during the different incubation periods. The results demonstrated that Lc. Lactis 537 significantly reduced the initial concentration of AFM1 in both milk and PBS after 24 h of incubation. Moreover, the presence of inulin or KP enhanced the binding and reduction capacity of Lc. Lactis 537. This suggests that the synbiotic effect where probiotic bacteria like Lc. Lactis work in synergy with prebiotics such as inulin or KP could play a critical role in the removal of AFM1 from contaminated substances. In conclusion, the synbiotic of Lc. Lactis 537 with inulin or KP represents a promising biological approach for AFM1 detoxification, and further research is warranted to explore its potential applications in food safety.

An assessment of the prevalence of Aflatoxin M1 level in milk and milk powder based on high performance liquid chromatography and dietary risk assessment

Milk is susceptible to Aflatoxin M1 (AFM1) contamination, mainly through consumption of contaminated animal's feed. The natural occurrence of aflatoxin M1 (AFB1) has been surveyed in samples of milk and milk powder. Samples collected from different regions of Saudi Arabia during the period from 2013 to 2021 were subjected to high-performance liquid chromatography analysis, and (AFB1) was quantified with detection limits of 0.5 µg/kg. The Saudi Food and Drug Authority has taken strong actions to limit AFM1 contamination, increase aflatoxin control, and modify the regulations. A study analyzed 363 randomly collected milk samples (168 milk, 195 milk powder) from Saudi Arabia using LC-MS/MS. Out of the 363 samples, 20 were positive for AFM1, with 343 were within the limits. One out of the 168 milk samples and 19 out of the 195 milk powder samples exceeded the limits, with seven originating from Saudi Arabia. The highest AFM1 concentration (3.97 µg/kg) was found in the Saudi samples. Saudi Arabia's mycotoxin regulations significantly reduced AFM1 contamination in milk, which is not considered a serious health hazard.

Quantitative Risk Assessment of Aflatoxin M1 Related to the Consumption of Raw Cow's Milk in Daloa (Côte d’Ivoire)

Cow's milk represents a potential health risk for consumers. The objective of this work is to assess the sanitary quality of raw cow's milk produced and consumed by the populations of Daloa. For this purpose, a total of 30 raw milk samples were collected from 3 raw cow's milk extraction points in the city of Daloa. Mycotoxins were determined using gas chromatography. The results showed that 100% of the analyzed samples were contaminated with aflatoxin M1 (AFLM1). These results indicated that the aflatoxin M1 levels in the analyzed samples exceeded the maximum limit (ML) set by European regulations. To assess the risk of contamination for the population of Daloa, a survey was conducted among consumers of raw cow's milk. A total of 388 individuals were interviewed to gather their opinions. The survey involved a form with questionnaires related to the objectives of the study. This form provided information on identity, marital status, consumption patterns, frequency, quantity, and the socio-economic characteristics of the consumers. The results showed that the risk of liver cancer related to the consumption of raw cow's milk in the city of Daloa is approximately 36.08% to 36.16%; representing 36,080 to 36,150 cases per 100,000 inhabitants. Thus, to ensure consumer safety, good hygiene practices in the preservation of feed for cattle and the construction of enclosures for them must be implemented.

Aflatoxin M1 level and risk assessment in milk, yogurt, and cheese in Tabriz, Iran

Aim and backgroundThe objective of this study was to investigate the presence of aflatoxin M1 (AFM1) in milk, yogurt, and cheese samples collected from Tabriz, Iran. Additionally, the study conducted a risk assessment related to the consumption of milk and dairy products within Tabriz city. Study methodFor this study, 56 samples (raw milk, pasteurized milk, ultra-high temperature milk (UHT), traditional yogurt, pasteurized yogurt, traditional cheese, and pasteurized cheese) were collected randomly in Tabriz from December 2021 to March 2022. The analysis was carried out using liquid chromatography, which was equipped with a fluorescence detector. The estimated dietary intake (EDI) and the hazard index (HI) were calculated for the risk assessment. Results and discussionAFM1 was detected in all samples. The highest concentration of AFM1 was observed in traditional cheese (P < 0.05). The lowest concentration was observed in UHT milk and there were no significant differences between the various milk types and pasteurized yogurt (P > 0.05). Moreover, in all samples, the levels of AFM1 were below the maximum limit permitted by Iranian national standards. AFM1 levels in traditional yogurt exceeded the European Union's permissible limit in 25% of the samples. The HI in all samples was less than one for both adult and child consumers, except for milk samples for children, which were more than one and indicated a medium risk. In conclusion, the levels of contamination in milk and dairy products and risk assessment appear not to pose a public health risk to Tabriz consumers.

The relationship between aflatoxin M1 and immunoglobulin levels in cows' colostrum.

The purpose of the present research was to assess the amounts of aflatoxin M1 (AFM1) and immunoglobulin (IgA, IgG, and IgM) in cow colostrum samples, as well as their relationship. The sampling involved 90 cows (54 Montofon and 36 Simmental) from 15 independent farms. An appropriate number of samples from the total mixed ration (TMR) used in feeding the cows were collected simultaneously with the colostrum samples. AFB1 in feed, AFM1, and immunoglobulin (IgA, IgG, and IgM) levels in colostrum were evaluated using the ELISA method. The AFM1 level in colostrum samples exceeded the maximum allowed values for raw milk. Ig levels were higher in Montofon-breed cows' colostrum than in Simmentals. However, it was determined that neither the breed nor the lactation number significantly affected the colostrum Ig level. It was determined that there was no linear relationship between the number of lactations and immunoglobulin levels or between AFM1 and immunoglobulin levels in colostrum. Similarly, it was determined that there was no linear relationship between the AFB1 level in the feed and the AFM1 level in the colostrum of animals consuming these feeds.

Aflatoxin M1 levels in urine and breast milk of lactating mothers in Kuala Lumpur, Malaysia

Aflatoxins are carcinogens that can contaminate food and affect various body organs especially liver and kidney. When consumed, aflatoxin B1 (AFB1) is partially metabolised into aflatoxin M1 (AFM1), which is excreted in the urine. Breast milk may also contain AFM1 due to maternal dietary intake from contaminated food. This cross-sectional study aimed to determine the levels of AFM1 in both urine and breast milk among breastfeeding mothers (n = 256). The mother’s demographic information was collected during recruitment. Mothers were then scheduled for an appointment to provide a morning urine sample along with five to ten mL samples of breast milk. AFM1 levels in both samples were analysed using an enzyme-linked immunosorbent assay (ELISA). Spearman’s rho and Chi-square were used to determine the associations between mean levels of AFM1 in urine and breast milk. Findings show 68.0% of urine samples were contaminated with AFM1 (mean levels = 0.08 ± 0.04 ng/mL), while 14.8% of breast milk samples had AFM1 (mean levels = 5.94 ± 1.81 ng/kg). Urine AFM1 levels were not significantly associated with AFM1 levels in breast milk (p > 0.05). This study can act as a baseline for future research examining long-term aflatoxin exposure among both mothers and infants.

Assessing the Biodetoxification Potential of Enterococcus faecium on Aflatoxin M1 in Fresh Raw Cow Milk

Study’s Novelty/Excerpt This study contributes to the field of food safety by exploring the bio-detoxification potential of E. faecium isolates from locally fermented cow milk for reducing Aflatoxin M1 (AFM1) contamination. By employing both biochemical and molecular methods to identify and utilize these isolates, the research provides innovative insights into an environmentally friendly and health-beneficial approach to mitigating aflatoxin contamination. The findings demonstrate a significant AFM1 binding capacity of E. faecium, highlighting its potential as a practical and safe biocontrol agent, which is critical for improving milk safety standards and public health protection. Full Abstract The adverse effects of aflatoxins on the economy and public health have prompted research into strategies to prevent their contamination in food and feed. Biological methods have become popular because they are environmentally friendly and beneficial for health. This research aims to determine the bio-detoxification potential of E. faecium, on Aflatoxin M1 (AFM1) in raw cow milk. Biochemical and molecular methods were used to identify the E. faecium isolates obtained from locally fermented cow milk (Nono). Three (3) distinct sampling locations in the Zaria metropolis, Dan-Magaji, Kufena, and Gabari, were used to gather nine (9) fresh milk samples. A quick test kit was used to screen the samples for AFM1 contamination. To determine the level of contamination, AFM1-contaminated samples were analyzed using High-Performance Liquid Chromatography (HPLC) analysis. The isolates were injected into the tainted milk samples at a cell density of 1.5 x 108cfu/mL and 3.0x108cfu/mL for 30 and 60 minutes at 4 and 37 degrees Celsius. The amount of unbound AFM1 in the samples was measured using HPLC analysis and surface binding assay. "ANOVA" single factor and two ways were used to analyze the data. All collected raw milk samples were contaminated with aflatoxin M1 at concentrations exceeding the EU/NAFDAC limit of ≤0.05 µg/L. The isolates bound AFM1 at 35-45% rates at a cell concentration of 3.0x108 cfu/mL at 37°C for 60 minutes. This research suggests that E. faecium could be an effective option for reducing AFM1 contamination in milk samples due to its harmless nature and recognition as generally safe. Additionally, regulatory agencies should implement thorough monitoring to ensure AFM1 levels in milk and milk products remain below acceptable limits.

Risk Assessment of AFM1 in Raw Milk and Dairy Products Produced in Armenia, a Caucasus Region Country: A Pilot Study.

This paper presents the first assessment of dietary exposure to aflatoxin M1 (AFM1) and associated health risks through milk and dairy product consumption in Armenia. Data on AFM1 in raw milk were obtained from an annual residue monitoring program. Additionally, commonly consumed dairy products (pasteurized milk, cheese, sour cream, curd cheese) were sampled, considering the sources of raw milk used by dairy companies. Per capita consumption of raw milk was sourced from national food balance databases, while individual consumption data for dairy products was collected via a 24 h recall survey with 1400 adult respondents. Detectable levels of AFM1 were observed in 7.14% of raw milk samples (up to 0.334 μg/kg) and, albeit at lower amounts (up to 0.009 µg/kg), in 30% and 40% of sour cream and curd cheese, respectively. The AFM1 levels were lower than the national maximum permitted level (0.5 μg/kg); however, levels in raw milk exceeded the EU ML (0.05 μg/kg). The estimated margin of exposure values for dairy products indicated no significant risk, whereas a reasonable worst-case estimate, using the measurable levels of AFM1 in raw milk consumption indicated a potential public health concern. This study provides a scientific basis for evaluating aflatoxin issues in the Caucasus area.

Aflatoxin M1 Exposure and Health Risk Assessment in Children and Adults due to Pasteurized Milk Consumption in Addis Ababa, Ethiopia

Milk and dairy products stand as essential sources of nutrition across all age groups. However, the presence of Aflatoxin M1, particularly common and risky for young children, necessitates careful assessment of milk. This study, conducted in Addis Ababa, Ethiopia, aimed to evaluate the prevalence of Aflatoxin M1 using High-Performance Liquid Chromatography in pasteurized milk and assess associated health risks using deterministic techniques. The prevalence of Aflatoxin M1 in pasteurized milk was 56.6%, with Aflatoxin M1 levels ranging from 0 to 6.27 μg/L and a mean value of 1.237 μg/L. The risk assessment revealed substantial Aflatoxin M1 exposure risk from pasteurized milk consumption, as reflected by margin of exposure values &lt;10,000, specifically 25.9, 109.6, and 380 for children aged 2–5, 6–9, and adults, respectively. The hazard index values for pasteurized milk consumers were 110, 26, and 7.5 for children aged 2–5, 6–9, and adults, respectively. Furthermore, cancer risk calculations yielded values of 0.18, 0.04, and 0.01 per 100,000 population for children aged 2–5, 6–9, and adults, respectively, with an average potency of 0.007978 cases per 100,000/yr ng Aflatoxin M1/kg bw/day. Notably, children aged 2–5 and 6–7 face elevated risks, whereas adults face relatively lower risks.

Aflatoxin M1 mitigation by novel biological agents and evaluation of bioaccessibility with enzymatic digestion in milk

Aflatoxin M1 (AFM1) is a metabolite of AFB1 that is formed in the liver and excreted in the mammary glands of ruminants who fed an AFB1-contaminated feed. This study focused on the AFM1 binding ability of biological agents including lactic acid bacteria (Leuconostoc mesenteroides) and yeast (Saccharomyces cerevisiae), chitosan as a biopolymer, and inulin as a prebiotic besides their effects on the AFM1 bioaccessibility in milk. Bioaccessibility refers to the amount of a contaminant in food that can reach the systemic circulation and exert its toxic effects on the body. In vitro gastrointestinal digestion model developed by RIVM for specifically mycotoxins was employed for assessing AFM1 bioaccessibility. Moreover, the colon phase was enzymatically simulated to evaluate the state of bound and unbound AFM1 that passed from the intestine to the colon and excreted from the body. Unbound AFM1 levels were determined by high-performance liquid chromatography (HPLC). The bound AFM1 percentages after incubation varied between 26.7% and 50.9%, and the best binder was found as S. cerevisiae while chitosan showed the lowest binding level. Following in vitro digestion practice, the lowest bioaccessibility after small intestine (29.30 ± 2.29%) digestion was acquired with S. cerevisiae, however; the lowest bioaccessibility after the colon phase (51.55 ± 3.38%) was acquired with L. mesenteroides. On the other hand, L. mesenteroides and chitosan were found more stable binders through the gastrointestinal tract (GIT). The present results showed that the bound AFM1 levels in food and absorbed from the gastrointestinal tract were affected by natural binders.

The content of aflatoxin M1 in the milk of cows from Turkish farms: the effect on milk quality and the effectiveness of mycotoxin binding by a claybased adsorbent

The aim of this study was to evaluate the concentration of aflatoxin M1 (AFM1) in milk from Holstein-Friesian cows on local farms located in two different cities in Turkey, to investigate the effect of this mycotoxin on milk quality and seasonal variation, and to investigate the efficacy of a commercial clay-based binder. As part of the study, milk samples from 144 dairy cows were analyzed for the presence of AFM1 prior to the use of a clay-based toxin binder. As a result of this analysis, 26.9% of milk samples from individual animals had AFM1 levels exceeding the U.S. permissible limit of 0.5 µg/kg. In addition, AFM1 was detected in 36.5% of winter and 18.6% of summer milk samples. The presence of AFM1 caused a decrease in milk fat, dry matter, and protein levels. The affected animals were further divided into two groups: control group (n = 14) and experimental group (n = 26). The animals of the experimental group were fed 25 g/animal of clay-based binder toxin daily. The treatment group showed a gradual decrease in AFM1 levels by 24.4% on day 4 and 48.9% on day 7. In addition, the fat, non-fat solids, and protein content of milk increased significantly. As a result, a high level of AFM1 contamination in milk was detected, which can be assumed to negatively affect the quality of milk production. The use of clay-based toxin binders may be an effective method to improve milk quality and protect animal and consumer health.

Reduction and binding of aflatoxin M1 in milk by Lactobacillus plantarum and Lactobacillus brevis isolated from Siahmazgi cheese

This study aimed to diagnose the ability of two probiotic strains isolated from Siahmazgi cheese to reduce the concentration of aflatoxin M1 (AFM1), which was able to reduce it up to 50%. Two strains of Lactobacillus isolated from local Siahmazgi cheese, were inoculated into raw milk containing 10 ng/mL AFM1. AFM1 levels were assessed by HPLC at 0, 24, 48 and 72 h. Also, for the assessment of the possible reduction of AFM1 by non-viable bacterial cells, heat treatment was applied in milk. In general, significant differences were observed between the control group and AFM1 contaminated milk samples containing probiotics during 72 h of refrigeration (p < 0.05). In the presence of Lactobacillus brevis, Lactobacillus plantarum and mixture probiotics, the concentrations of AFM1 ranged from 0.102 ± 0.004 ng/mL to 0.052 ± 0.002 ng/mL, 0.114 ± 0.002 ng/mL to 0.074 ± 0.003 ng/mL and 0.108 ± 0.003 ng/mL to 0.065 ± 0.002 ng/mL, respectively. Also, in the heated group, just a decrease was observed in the first 24 h. The results showed that native Iranian strains of Lactobacillus have good potential in reducing AFM1 in milk. The time factor is effective in reducing AFM1 by living bacterial cells.

Detection of aflatoxin in raw and pasteurized milk by high-performance liquid chromatography (HPLC) in central Ethiopia

Aflatoxins are a group of structurally related mycotoxins produced by the Aspergillus flavus, Aspergillus parasiticus, and Aspergillus nomius species as secondary metabolites. Well-known forms of Aflatoxin are AFB1, AFB2, AFG1, AFG2, AFM1, and AFM2. aflatoxin B1 is the most prevalent one. It can be metabolized in the liver and excreted as aflatoxin M1 in milk. Both forms have mutagenic and carcinogenic effects. In Ethiopia, there is limited information on the occurrence and contamination level of aflatoxin in raw and pasteurized milk. The present study was conducted in the Addis Ababa milk shed area to detect and quantify the level of Aflatoxin M1 in raw and pasteurized milk. A cross-sectional study was conducted from October 2020 to May 2021 on a total of 114 cow milk samples consisting of 60 raw milk and 54 pasteurized milk samples with the aim of detecting and quantifying the amount of aflatoxin M1 in raw and pasteurized milk in central Ethiopia by high-performance liquid chromatography (HPLC) using C18 column with fluorescence detector. AFM1 was detected in 79 (69.3%) of the 114 tested milk samples. The maximum and mean concentrations were 0.893 µg/L and 0.0465 µg/L, respectively. 25.4% of them contain AFM1 above the maximum limit of EU (0.05 µg/L), and 1.8% contained above the maximum limit of CES278 and FDA (0.5 µg/L). 26.7% of the samples from Sebata and 6.7% from Sululta contain above the maximum limit of EU (0.05 µg/L). Higher contamination of AFM1 was detected in pasteurized milk (96.3%) than in raw milk (16.7%). 35.2% of pasteurized and 16% of raw milk contained AFM1 above the maximum limit of EU0.05 µg /L. The study results showed a significant difference in AFM1 occurrence with feed type, storage time, and milk type. The current AFM1 concentration level in raw and pasteurized milk was not safe for human consumption in the study areas. Due to its heat resistance, AFM1 is found in pasteurized milk and has great health effects. Creating awareness of feed management for feed producers and farmers and developing risk mitigation methods are crucial in order to reduce public health threats.

Importance of Rigorous and Ongoing Monitoring of Animal Feed Quality and Storage Conditions to Mitigate Aflatoxin M1 Contamination in Dairy Products in Iran: A Health Policy Brief

Background: Milk and dairy products are essential for global nutrition, and ensuring their safety is crucial. Aflatoxin M1 (AFM1), a carcinogen from contaminated animal feed, poses a significant threat to consumers. Objectives: This “health policy brief" highlights the critical need for meticulous and constant monitoring of Iran's animal feed quality and storage conditions to minimize AFM1 contamination in dairy products. Methods: Comprehensive review papers on AFM1 were reviewed in Iranian dairy products, drawing evidence from various databases. Results: The prevalence of AFM1 contamination in Iranian dairy products, particularly risky for children due to extensive consumption, exceeds safety limits, with livestock feed identified as the primary source. Public health demands rigorous monitoring practices, such as stricter feed quality and storage regulations, regular AFM1 testing, stakeholder collaboration, and public awareness. There are many benefits associated with these measures, including lowering AFM1 levels in dairy products, improving food safety standards, minimizing AFM1 exposure risks, especially for children, and increasing consumer confidence in the integrity of the Iranian dairy industry. Conclusions: Continuous monitoring of animal feed is crucial to safeguard public health and ensure the safety of Iranian dairy products, particularly for children. This comprehensive approach, collaboration, and public awareness are vital to mitigating AFM1 contamination and promoting Iran's safe and robust dairy industry.

Determination of aflatoxin M1 and ochratoxin A in breast milk in rural centers of Yazd, Iran: Exposure assessment and risk characterization.

Breast milk (BM) is considered as the best source of nutrition which could have prevention effects on various diseases in the first years of a child. Along with nutritive compounds, presence of contaminants such as mycotoxins in BM could be transmitted into neonate. The aim of this study was to determine the occurrence, levels, and factors associated with the presence of aflatoxin M1 (AFM1) and ocratoxin a (OTA) in BM samples of nursing mothers in rural centers of Yazd, Iran. The presence and average AFM1 and OTA concentration in 72 BM samples was measured by competitive ELISA. The demographic and diet parameters of nursing mothers were collected by a questionnaire and were analyzed using SPSS 18 software. AFM1 and OTA were detected in 63 (87.5%) and 47 (65.2%) samples with the mean concentration levels of 19.46 ± 13.26ng/L (ranges from 5.1 to 53.9) and 200 ± 160ng/L (ranges from 100 to 2460), respectively. Of these, 32 samples (50.7%) for AFM1 and 23 samples (48.9%) for OTA had values exceeding the limit set by the European Union regulation for infant foods (25ng/L for AFM1 and 500ng/L for OTA). It was also found that the risk of AFM1 and OTA occurrence in BM increased significantly with the consumption of beans, bread, cereals, fruit juice and crackers, and cream, respectively. This study showed that the estimated daily intake for AFM1 and OTA by 1month of age infants was 2.7 and 28.5ng/kg bw/day, respectively, while, as the age of the infant increased, the values were lower and close to 0.9 and 9.9ng/kg bw/day for AFM1 and OTA in 12months of age infants, respectively. The high occurrence and noticeable levels of AFM1 and OTA detected in this study indicated that some infants receive undesirable exposures to AFM1 and OTA with breast milk. Therefore, it is recommended that mothers are advised to avoid certain foods during pregnancy and breastfeeding that are likely sources of mycotoxins.